Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if BMS-181339 can shrink or slow the
growth of the cancer in patients with advanced or recurrent esophageal cancer. The safety of
this treatment will also be studied.